Astrazeneca Stock News

By Kim Han-joo SEOUL, Dec. 14 (Yonhap) -- British-Swedish pharmaceutical giant AstraZeneca said Tuesday that Samsung Biologics Co., the biotech arm of Samsung Group, will manufacture its antibody combination against COVID-19. Under an agreement valu

The National Primary Health Care Development Agency (NPHCDA) has admitted stock of one million expired AstraZeneca COVID-19 vaccine in Nigeria. The expired covid vaccine have become dangerous for human usage. No details of the acquisition timing or conditions were given by the federal government on the expired vaccine. However, the Executive Director of the The post 1m doses of expired COVID-19 AstraZeneca vaccine stocked in Nigeria appeared first on National Daily Newspaper .

Nigeria is going to destroy a million doses of AstraZeneca vaccine against Covid-19, a top health official has said, promising that the country will no longer be accepting jabs with short shelf life. Read Full Article at RT.com

A clear description on technological innovation, industry integration, regulatory possibilities and demographics covering some significant regions such as North America, Middle East, Latin America, Europe and Asia Pacific are covered in this Felodipine Sustained-Release Tablet market report. It

Japan’s new foreign minister has reaffirmed his country’s support in upholding the 2016 arbitral ruling that favored the Philippines in its maritime dispute with China in the South China Sea. West Philippine Sea (FILE PHOTO FROM AFP) The Department of Foreign Affairs (DFA) said this was conveyed by Japanese Foreign Minister Hayashi Yoshimasa during a phone call with DFA Secretary Teodoro Locsin Jr. on Dec. 8. According to the DFA, “Minister Hayashi expressed his strong opposition to unilateral attempts to change by force the status quo in the East and South China Seas.” Locsin said that the Philippines values Japan’s statements of support for the Arbitral Award and for an international law-based order in the South China Sea. HE further said that Japan’s “formal demonstrations of support send a message of respect for outcomes of diplomatic and legal processes, as well as strengthen the legal order over the seas.” The Philippine top diplomat also echoed President Duterte’s statement at the 13th ASEM Summit Retreat that “there can be no other acceptable basis for a just maritime order but the law, particularly the 1982 UNCLOS.” “All countries – big and small – must adhere to the rule of law faithfully and consistently.

Click to expand Image A nurse prepares a dose of the AstraZeneca Covid-19 vaccine at Kenyatta National Hospital in Nairobi, Kenya, March 5, 2021. © 2021 AP Photo/Ben Curtis (Nairobi) Kenyan authorities should amend measures requiring everyone seeking government services to be fully vaccinated to avoid undermining basic rights. The proposed measures, announced less than a month ago, will go into effect on December 21, 2021. Given that approximately 10 percent of adults in Kenya had been vaccinated by the end of November, based on Health Ministry figures, the requirement risks violating the rights to work, health, education, and social security for millions of Kenyans. While the government has an obligation to protect its people from serious public health threats, the measures must be reasonable and proportional, said Adi Radhakrishnan, Africa research fellow at Human Rights Watch. Vaccination coverage hinges on availability and accessibility, and the governments new measures could leave millions of Kenyans unable to get essential government services. On November 21 Kenyas cabinet secretary for health, Mutahi Kagwe, announced that beginning December 21, authorities will require anyone seeking government services to provide proof of full Covid-19 vaccination.

Los Angeles, USA, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 | DelveInsight There are approximately 150+ key companies developing Glioblastoma therapies. The companies with Glioblastoma drug candidates in the most advanced stage are Kintara Therapeutics, Diffusion Pharmaceuticals, Celgene Corporation, Bio-Thera Solutions. DelveInsight''s " Glioblastoma Pipeline Insight " report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Glioblastoma pipeline landscapes. It comprises Glioblastoma pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Glioblastoma therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Glioblastoma pipeline products. Some of the key takeaways from the Glioblastoma Pipeline Report Major companies such as Celgene Corporation, Myeloid Therapeutics, Genenta Science, Inovio Pharmaceuticals, Apogenix, Oncoceutics, Laminar Pharmaceuticals, Celgene Corporation, Bristol-Myers Squibb, Kintara Therapeutics, Kazia Therapeutics, Oncotelic Therapeutics, AstraZeneca, Genentech, Accendatech, Pfizer, Curtana Pharmaceuticals, Crimson BioPharm, Hope Biosciences, and others are developing potential drug candidates to improve the Glioblastoma treatment scenario.

The Organised Private Sector (OPS) has warned Europe, Bill Gate Foundation (BGF) and the Global Alliance for Vaccines and Immunization (GAVI) not to make Nigeria a dumping ground for expired COVID-19 vaccines. The warning came following the report that the Federal Government destroyed 1million doses of expired AstraZenecas COVID-19 vaccine. The private sector group said [] The post OPS Warns Europe, BGF Against Distributing Expired COVID-19 Vaccines appeared first on InsideBusiness - Business News in Nigeria .

As of today, COVID-19 booster shots will be available for all Bahamians and residents who are 18 years and older, the Ministry of Health and Wellness announced. Individuals who got their second shot of Pfizer or AstraZeneca at least six months ago will be eligible for booster shots. Individuals who got their Johnson & Johnson shot … The post Booster shots available for residents 18 and older appeared first on The Nassau Guardian .

BEGINNING today, Jamaica will offer a booster shot to all those 18 years and older who have received a single dose of the Johnson & Johnson vaccine. The booster can be given with the Johnson & Johnson vaccine two to six months after the administration of the primary vaccination, or with the Pfizer vaccine six months after the primary vaccination, the Ministry of Health reported. Also starting today, adults 60 years and older and health-care workers will be given a booster dose of the other COVID-19 vaccines. This development comes in the wake of the ministry''s finalisation of its evaluation and benefit analysis of administering an additional dose of the authorised COVID-19 vaccines to key members of the population. The ministry recommends that a booster dose of the Pfizer vaccine be offered six months or more after the completion of the initial doses that may have consisted of either mRNA (Pfizer) or viral vector vaccine (AstraZeneca and Johnson & Johnson). The move is in line with a Cabinet decision for boosters to be given to key populations at increased risk of severe illness from COVID-19, increased risk of waning and/or lower protection, and who could pose increased risk of transmission to vulnerable populations.

Two dose COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca induce a lower amount of antibodies against the Omicron coronavirus strain compared to previous variants, according to an Oxford

"Because of the new version of Omicron, a third dose of RNA vaccine must be given because it really protects. The first two doses of AstraZeneca protect only 20%. However, if a booster dose is given to two previous Pfizer ones, the protection against Omicron is equalized to the one against the Delta variant - 85% it is certain that you will not get sick or if it happens, it will be easier to deal with". This was explained by Prof. Todor Kantardjiev, vaccination consultant of the Sofia Municipality, on the air of Nova TV. He stressed that Omicron is more contagious, but it is milder. Vaccines are slightly weaker against it, and those who have already suffered from COVID-19 can become infected again. The professor predicts that the death rate may rise due to unprovided medical care. According to him, the new cases of coronavirus in our country are decreasing quite slowly, because 10 patients infect 9 people. " We cannot expect a sharp decline in cases. There are many people in intensive care units and there are many dead ," he said.

New Jersey, United States,- Verified Market Research has recently published a research report titled, Healthcare Associated Infections Treatment Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used

Today''s Daily Dose brings you news about AstraZeneca''s new long-term data related to cancer drug Calquence; superior efficacy of Novartis'' Scemblix compared to Bosulif in chronic myeloid leukemia; and ImmunoGen''s updated initial safety and efficacy findings from its phase 1b/2 study of IMGN632 in combination with Vidaza and Venclexta in patients with relapsed/refractory acute myeloid leukemia.

"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are